OM:CAMXPharmaceuticals
Assessing Camurus (OM:CAMX) Valuation After New 2026 Growth Guidance And Portfolio Progress
Why Camurus’ new 2026 guidance matters for shareholders
Camurus (OM:CAMX) has set fresh 2026 guidance, flagging expected revenues of SEK 2.6b to SEK 2.9b and an operating result of SEK 0.9b to SEK 1.2b, alongside several portfolio milestones.
See our latest analysis for Camurus.
Camurus’ new 2026 guidance follows a 9.5% year to date share price return and a 14.2% total shareholder return over the past year, which builds on a very large 3 year total shareholder return of about 19x. This...